UPDATE: Shaikin adds that Clemens was suspended based on a “non-analytical” violation, which is the same situation we saw with the 14 suspensions from the Biogenesis scandal last year. The evidence could include things like documents, clinic records and shipping information.
8:01 p.m. ET: According to Bill Shaikin of the Los Angeles Times, Pirates minor league right-hander Michael Clemens has been suspended 68 games for “possession and use” of human growth hormone.
Clemens, 21, was selected in the 16th round out of a McNeese State University back in June. He had a 1.00 ERA and 20/5 K/BB ratio over his first 18 professional innings as a reliever with the Pirates’ rookie ball team in Bristol, Virginia.
Why 68 games? Danny Wild of MiLB.com provides the explanation:
Under the rules of the new Minor League Drug Prevention and Treatment Program for Rookie and Short-Season leagues, a first violation receives a discipline of 80 games or the total number of regular-season games in the league, whichever is shorter.
And so, Clemens’ first pro season ends on a sour note and the suspension will roll over into 2015.
Here’s a pretty good way to finally break out of that turkey-induced Thanksgiving tryptophan coma.
It’s a compilation of the 10 longest home runs from the 2015 season, with MLB.com’s Statcast technology providing data along the path of each blast …
Jon Morosi of FOX Sports reports that the Tigers are in discussions with free agent starter Jordan Zimmermann. His sources have told him that the talks have become “serious”.
Zimmermann, 29, has a career 3.32 ERA across parts of seven seasons in the majors. He finished fifth in National League Cy Young Award balloting in 2014, finishing with a 2.66 ERA and a 182/29 K/BB ratio over 199 2/3 innings.
Among starters who have amassed at least 1,000 innings since 2009, only Cliff Lee, Dan Haren, Madison Bumgarner, and Zack Greinke have compiled a better strikeout-to-walk ratio than Zimmermann’s 4.09. While he doesn’t have the star power of other free agents such as Greinke or David Price, the Tigers would certainly improve their rotation by bringing him on board.
Having already added Jesse Chavez and J.A. Happ to the mix and re-signing Marco Estrada early in the offseason, Blue Jays interim GM Tony LaCava said the team will continue to pursue pitching upgrades, as Sportsnet’s Ben Nicholson-Smith reports. Nicholson-Smith added that LaCava declined to comment on free agent ace David Price. It is believed that the Jays will not pursue Price and other big-name free agent starting pitchers given their November activity.
The Jays re-signed Estrada to a two-year, $26 million deal on November 13, acquired Chavez from the Athletics in exchange for reliever Liam Hendriks on November 20 and signed Happ to a three-year, $36 million deal on Friday.
Nicholson-Smith notes in a column on Sportsnet that the Jays need to address the bullpen in particular. That is especially true after swapping Hendriks, who had a career-best 2.92 ERA out of the Jays’ bullpen in 2015, for a back-end starting pitcher.
Jon Heyman of CBS Sports spoke to an anonymous baseball executive, who said that Nationals closer Jonathan Papelbon is “untradeable”. The Nationals are hoping to trade both Papelbon and the man he displaced, Drew Storen.
Papelbon has a poor reputation in baseball, particularly after a dugout altercation with superstar outfielder Bryce Harper. Focusing strictly on what he does on the field, Papelbon still gets the job done. The 35-year-old finished the last season with a combined 2.13 ERA, 24 saves, and a 56/12 K/BB ratio over 63 1/3 innings between the Phillies and Nationals.
The Nationals owe Papelbon $11 million for the 2016 season.